One Cancer Voice: Plotting a route out of the pandemic and towards world-leading cancer services
Governments across the UK have bold ambitions to improve cancer [...]
HIF-2α inhibitor belzutifan to be fast-tracked for approval for VHL kidney cancer
Kidney cancers frequently have mutations in a gene called the [...]
Nivolumab/cabozantinib combination recommended for EMA approval for first-line kidney cancer
The Committee for Medicinal Products for Human Use (CHMP) of [...]
Warning over COVID-19 cons
The NHS has teamed up with the police and security [...]
Past COVID-19 infection provides some immunity but people may still transmit the virus
A Public Health England (PHE) study (SIREN) finds past infection [...]
Obesity diminishes response to immunotherapy in kidney cancer
In this study, the researchers looked at the interaction between [...]
Percutaneous thermoablation for small renal masses
This study looked at the survival of patients suitable for [...]
AstraZeneca/Oxford University’s COVID-19 vaccine UK rollout
AstraZeneca and Oxford University’s COVID-19 vaccine is being rolled out [...]
2020 top stories in kidney cancer
This article summarises the key breakthroughs in the treatment of [...]
Impact of cytoreductive nephrectomy in patients with metastatic kidney cancer
Cytoreductive nephrectomy is the removal of the tumour to reduce [...]
